First Wave BioPharma drops on reverse stock split announcement
** Drug Developer First Wave BioPharma Inc's shares FWBI.O
fall ~17% to 13 cents
** Co announces 1-for-30 reverse share split of its common
stock
** Share split aimed at increasing the per share trading
price to meet the minimum bid price requirement for continued
listing on Nasdaq urn:newsml:reuters.com:*:nGNXNwQvq
** FWBI will trade on a split-adjusted basis from Friday,
Aug. 26
** Reverse stock split will reduce the number of outstanding
shares from about 42 million to about 1.4 million
** Including session losses, stock lost ~90% YTD
(Reporting by Khushi Mandowara)
((Khushi.Mandowara@thomsonreuters.com;))
Recent news on GridAI Technologies
See all newsBrief: Gridai Technologies Corp - Enters $2.54 Million Private Placement Of Shares And Warrants - SEC Filing
Brief: IBN Announces Latest Episode Of The Techmediawire Podcast Featuring Marshall Chapin, CEO Of Grid Ai Corp.
Brief: Entero Therapeutics Terminated Interim CEO And Chairman Richard Joel Paolone Effective Immediately - SEC Filing
Brief: Entero Therapeutics Inc - Now Offering 15.2 Million Shares Of Common Stock
Brief: Entero Therapeutics Inc Subsidiary Immunogenx Enters Settlement Agreement